Special report  by epic research 30 jan 2013
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
123
On Slideshare
123
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. 30TH January 2013DAILY CHARTIST VIEW
  • 2. HIGHLIGHTSA  Highlights  Nifty traded volatile and ended negative on Tuesday  Nifty Future ended 27.80 points down at 6049.40  IVRCL future sell call hits both tgs and made low 30.95 and Sun Tv future sell call remained unexecuted.  Investors’ are advised to book full profit in IVRCL future and take position in fresh calls provided below.  Buy ITC future above 306 for targets 309/313 with sl 301.45  Sell Biocon future below 278 for targets 275/271 with sl 282.45.  Past Performance:  IVRCL Infra sell call hits final tg 34, made low 30.95.  Sun Tv future sell call remained unexecuted.  Jet Airways buy call hits final tg 630.  HUL future sell call made low 466.50.  Andhra Bank future sell call made low 107.70  ITC future buy call made high 300.45.  Bharti Airtel future buy call made high 369.30  .  Havells sell call hit both targets.
  • 3. ITC FUTURE – CHANNEL LINE BUY ABOVE306 FOR TARGETS 309/313 SL 301.45 BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235 Buy ITC future above 306 ITC future is making a Channel Line pattern on 15 minutes charts. Currently trading at 304.80 Investor’s are advised to buy above 306, break out is yet to come. Targets are 309/313 and SL is recommended at 301.45. This is an intraday call as the pattern is forming on 51 minutes chart.
  • 4. BIOCON FUTURE – RISING WEDGE SELL BELOW 278 FOR TARGETS 275/271 SL 282.45 Sell Biocon future below 278 Biocon future is making a Rising wedge pattern on 15 minutes chart. Currently trading at 278.95 Investors’ are advised to sell below 278 for targets 275/271, Breakout is yet to come. Targets are 275/271 and SL recommended is 282.45
  • 5. DisclaimerThe information and view in this report, our website & all the service we provideare believed to be reliable, but we do not accept any responsibility (or liability) forerrors of fact or opinion. Users have the right to choose the product/s that suitsthem the most.Sincere efforts have been made to present the right investment perspective. Theinformation contained herein is based on analysis and up on sources that weconsider reliable.This material is for personal information and based upon it & takes noresponsibilityThe information given herein should be treated as only factor, while makinginvestment decision. The report does not provide individually tailor-madeinvestment advice. Epic research recommends that investors independentlyevaluate particular investments and strategies, and encourages investors to seekthe advice of a financial adviser. Epic research shall not be responsible for anytransaction conducted based on the information given in this report, which is inviolation of rules and regulations of NSE and BSE.The share price projections shown are not necessarily indicative of future priceperformance. The information herein, together with all estimates and forecasts, canchange without notice. Analyst or any person related to epic research might beholding positions in the stocks recommended. It is understood that anyone who isbrowsing through the site has done so at his free will and does not read any viewsexpressed as a recommendation for which either the site or its owners oranyone can be held responsible for . Any surfing and reading of the information isthe acceptance of this disclaimer.All Rights Reserved. Investment in equity & bullion market has its own risks.We, however, do not vouch for the accuracy or the completeness thereof. we are notresponsible for any loss incurred whatsoever for any financial profits or losswhich may arise from the recommendations above epic research does not purportto be an invitation or an offer to buy or sell any financial instrument. Our Clients(Paid Or Unpaid), Any third party or anyone else have no rights to forward orshare our calls or SMS or Report or Any other information provided by us to/withanyone which is related directly or indirectly with them. If found so, then SeriousLegal Actions can be taken.